Macrophages orchestrate breast cancer early dissemination and metastasis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29295986.
- Also identified by DOI 10.1038/s41467-017-02481-5 and PMC identifier 5750231.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Cancer cell dissemination during very early stages of breast cancer proceeds through poorly understood mechanisms. Here we show, in a mouse model of HER2<sup>+</sup> breast cancer, that a previously described sub-population of early-evolved cancer cells requires macrophages for early dissemination. Depletion of macrophages specifically during pre-malignant stages reduces early dissemination and also results in reduced metastatic burden at end stages of cancer progression. Mechanistically, we show that, in pre-malignant lesions, CCL2 produced by cancer cells and myeloid cells attracts CD206<sup>+</sup>/Tie2<sup>+</sup> macrophages and induces Wnt-1 upregulation that in turn downregulates E-cadherin junctions in the HER2<sup>+</sup> early cancer cells. We also observe macrophage-containing tumor microenvironments of metastasis structures in the pre-malignant lesions that can operate as portals for intravasation. These data support a causal role for macrophages in early dissemination that affects long-term metastasis development much later in cancer progression. A pilot analysis on human specimens revealed intra-epithelial macrophages and loss of E-cadherin junctions in ductal carcinoma in situ, supporting a potential clinical relevance.
Medical subject headings
- Breast Neoplasms
- Macrophages